Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granix with Melphalan in Multiple Myeloma ASCT
NCT02112045Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of granisetron in multiple myeloma (MM), sponsored by Washington University School of Medicine. Started Jan 2015; status: terminated.
02
Drugs
granisetron
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02112045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112045.